Related Experiment Video
Updated: Jun 15, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Ketamine and botulinum: a safe combinationfor the management of childhood strabismus
Manon Owen1, Carmel P Noonan, Mohammed Al-Khalid
1Department of Ophthalmology, Warrington and Halton Hospitals NHS Foundation Trust, Warrington, UK.
Insights
Ketamine anesthesia for strabismus surgery in children is generally safe, with a low incidence of side effects like hallucinations and sleep disturbances. Ptosis, a botulinum toxin side effect, typically resolves within six weeks.
Area of Science:
- Pediatric Anesthesiology
- Ophthalmology
- Pharmacology
Background:
- Strabismus correction in children often involves botulinum toxin injections.
- Ketamine is used for anesthesia in pediatric procedures.
- Evaluating side effects of ketamine and botulinum toxin is crucial for patient safety.
Purpose of the Study:
- To determine the prevalence of ketamine side effects in children undergoing botulinum toxin injections for strabismus.
- To assess the incidence, severity, and duration of ptosis following botulinum toxin treatment.
Main Methods:
- Retrospective review of children who received ketamine anesthesia for strabismus surgery (1999-2006).
- Parental questionnaires assessed ketamine side effects (nightmares, sleepless nights, hallucinations) and ptosis.
- Telephone follow-up and medical record analysis provided further details.
Main Results:
- 12.4% of patients (12/97) experienced emergence reactions to ketamine.
- Two children had multiple ketamine side effects; ten had a single side effect.
- 18.6% of patients (18/97) developed ptosis, most resolving within 6 weeks.
- No life-threatening or sight-threatening adverse events were reported.
Conclusions:
- Intravenous ketamine anesthesia is a safe option for pediatric strabismus surgery with botulinum toxin.
- Potential side effects of ketamine include hallucinations and sleep disturbances.
- Ptosis is a common but generally transient side effect of botulinum toxin treatment for strabismus.
Aims:
To determine the prevalence of ketamine side effects in children receiving botulinum toxin injections for strabismus under ketamine anesthesia and to establish the prevalence, severity, and duration of ptosis in these children.
Methods:
Children who had undergone ketamine anesthesia for botulinum toxin injections (1999 to 2006) to correct strabismus were identified in a retrospective review. A questionnaire to establish occurrence of nightmares, sleepless nights, hallucinations (ketamine side effects), or ptosis (botulinum toxin side effect), was sent to parents or guardians. Details of side effects were obtained by telephone and the patients' medical records were analyzed.
Results:
Questionnaires were sent to 113 patients (total of 130 injections). Ninety-seven (114 injections) completed questionnaires were returned. Emergence reactions were experienced by 12 patients (12.4%). Two children experienced sleepless nights, nightmares, and hallucinations. The remaining 10 experienced one side effect only. Eighteen children had ptosis at their 2-week follow-up appointment, most which resolved within 6 weeks. There were no life-threatening or sight-threatening adverse events.
Conclusions:
Botulinum toxin injection under intravenous ketamine anesthesia can safely be used for children. Ketamine anesthesia may be associated with side effects, namely hallucinations and sleep disturbances.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Parenteral Anesthetics: Overview
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Depolarizing Blockers: Pharmocokinetics
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...